Table 2.

Relative Reduction in ILTFU Between Baseline and Intervention Periods per Province

Oct–Dec 2018Jan 2019–Dec 2020Relative Reduction ILTFU (95% CI), %
Newly Diagnosed PWTB, No.ILTFU, No. (%) (95% CI, %)Newly Diagnosed PWTB, No.ILTFU, No. (%) (95% CI, %)
KwaZulu-Natal32781 (24.8) (20.1–29.4)1999285 (14.3) (12.7–15.8)42.4 (28.5–53.7)
Gauteng921292 (31.7) (28.7–34.7)53991772 (32.8) (31.6–34.1)−3.5 (−14.7 to 6.5)
Western Cape1323296 (22.4) (20.1–24.6)93591627 (17.4) (16.6–18.2)22.3 (13.3–30.4)
Oct–Dec 2018Jan 2019–Dec 2020Relative Reduction ILTFU (95% CI), %
Newly Diagnosed PWTB, No.ILTFU, No. (%) (95% CI, %)Newly Diagnosed PWTB, No.ILTFU, No. (%) (95% CI, %)
KwaZulu-Natal32781 (24.8) (20.1–29.4)1999285 (14.3) (12.7–15.8)42.4 (28.5–53.7)
Gauteng921292 (31.7) (28.7–34.7)53991772 (32.8) (31.6–34.1)−3.5 (−14.7 to 6.5)
Western Cape1323296 (22.4) (20.1–24.6)93591627 (17.4) (16.6–18.2)22.3 (13.3–30.4)

Abbreviations: ILTFU, initial loss to follow-up; PWTB, person with tuberculosis.

Table 2.

Relative Reduction in ILTFU Between Baseline and Intervention Periods per Province

Oct–Dec 2018Jan 2019–Dec 2020Relative Reduction ILTFU (95% CI), %
Newly Diagnosed PWTB, No.ILTFU, No. (%) (95% CI, %)Newly Diagnosed PWTB, No.ILTFU, No. (%) (95% CI, %)
KwaZulu-Natal32781 (24.8) (20.1–29.4)1999285 (14.3) (12.7–15.8)42.4 (28.5–53.7)
Gauteng921292 (31.7) (28.7–34.7)53991772 (32.8) (31.6–34.1)−3.5 (−14.7 to 6.5)
Western Cape1323296 (22.4) (20.1–24.6)93591627 (17.4) (16.6–18.2)22.3 (13.3–30.4)
Oct–Dec 2018Jan 2019–Dec 2020Relative Reduction ILTFU (95% CI), %
Newly Diagnosed PWTB, No.ILTFU, No. (%) (95% CI, %)Newly Diagnosed PWTB, No.ILTFU, No. (%) (95% CI, %)
KwaZulu-Natal32781 (24.8) (20.1–29.4)1999285 (14.3) (12.7–15.8)42.4 (28.5–53.7)
Gauteng921292 (31.7) (28.7–34.7)53991772 (32.8) (31.6–34.1)−3.5 (−14.7 to 6.5)
Western Cape1323296 (22.4) (20.1–24.6)93591627 (17.4) (16.6–18.2)22.3 (13.3–30.4)

Abbreviations: ILTFU, initial loss to follow-up; PWTB, person with tuberculosis.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close